BRIEF

on Onco-Innovations Limited (isin : CA68237C1059)

Onco-Innovations Welcomes Professor Steven Jones as Senior Scientific Advisor

Onco-Innovations Limited announces the appointment of Professor Steven Jones as Senior Scientific Advisor. As Co-Director of the Genome Sciences Centre and Head of Bioinformatics, Jones is esteemed in genomics and cancer research. He will bolster Onco-Innovations' mission to advance cancer care through AI-powered precision oncology.

Steven Jones has made significant contributions to genomics and cancer research, holding accolades from the Royal Society of Canada and the Canadian Academy of Health Sciences. His role will involve guiding the scientific direction of Onco-Innovations' initiatives, focusing on AI-driven oncology solutions.

Collaborating primarily with Inka Health, Jones is set to enhance the company's AI platform, SynoGraph. Included in his duties are fostering collaborations, contributing to key scientific publications, and engaging in public communication to highlight the impact of Onco-Innovations' technologies.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Onco-Innovations Limited news